Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NAPROXEN\NAPROXEN Cause Muscular weakness? 204 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 204 reports of Muscular weakness have been filed in association with NAPROXEN\NAPROXEN. This represents 17.6% of all adverse event reports for NAPROXEN\NAPROXEN.

204
Reports of Muscular weakness with NAPROXEN\NAPROXEN
17.6%
of all NAPROXEN\NAPROXEN reports
158
Deaths
179
Hospitalizations

How Dangerous Is Muscular weakness From NAPROXEN\NAPROXEN?

Of the 204 reports, 158 (77.5%) resulted in death, 179 (87.7%) required hospitalization, and 174 (85.3%) were considered life-threatening.

Is Muscular weakness Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NAPROXEN\NAPROXEN. However, 204 reports have been filed with the FAERS database.

What Other Side Effects Does NAPROXEN\NAPROXEN Cause?

Fatigue (502) Mobility decreased (467) Off label use (462) Fibromyalgia (456) Folliculitis (449) Joint swelling (448) Psoriatic arthropathy (445) Glossodynia (434) General physical health deterioration (433) Hand deformity (431)

What Other Drugs Cause Muscular weakness?

ADALIMUMAB (3,605) METHOTREXATE (2,813) RITUXIMAB (2,621) ATORVASTATIN (2,494) PREDNISONE (2,236) ETANERCEPT (2,207) DALFAMPRIDINE (1,916) TOCILIZUMAB (1,790) FINGOLIMOD (1,769) SECUKINUMAB (1,747)

Which NAPROXEN\NAPROXEN Alternatives Have Lower Muscular weakness Risk?

NAPROXEN\NAPROXEN vs NAPROXEN\PSEUDOEPHEDRINE NAPROXEN\NAPROXEN vs NAPROXEN\SUMATRIPTAN NAPROXEN\NAPROXEN vs NARATRIPTAN NAPROXEN\NAPROXEN vs NASONEX NAPROXEN\NAPROXEN vs NATALIZUMAB

Related Pages

NAPROXEN\NAPROXEN Full Profile All Muscular weakness Reports All Drugs Causing Muscular weakness NAPROXEN\NAPROXEN Demographics